Simplex Trading’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $457K | Buy |
+1,446
| New | +$341K | ﹤0.01% | 3718 |
|
|
2026
Q1 | – | Sell |
-2,055
| Closed | -$407K | – | 9658 |
|
|
2025
Q4 | $389K | Buy |
2,055
+408
| +25% | +$78.4K | ﹤0.01% | 3545 |
|
|
2025
Q3 | $291K | Buy |
1,647
+1,107
| +205% | +$165K | ﹤0.01% | 4500 |
|
|
2025
Q2 | $61K | Buy |
+540
| New | +$57.7K | ﹤0.01% | 5734 |
|
|
2025
Q1 | – | Sell |
-542
| Closed | -$58K | – | 9129 |
|
|
2024
Q4 | $58K | Buy |
+542
| New | +$61.3K | ﹤0.01% | 5725 |
|
|
2023
Q3 | – | Sell |
-187
| Closed | -$12.3K | – | 9289 |
|
|
2023
Q2 | $13K | Buy |
+187
| New | +$14K | ﹤0.01% | 7173 |
|
|
2023
Q1 | – | Sell |
-368
| Closed | -$26.2K | – | 9637 |
|
|
2022
Q4 | $24K | Sell |
368
-243
| -40% | -$15.8K | ﹤0.01% | 6691 |
|
|
2022
Q3 | $32K | Sell |
611
-11,375
| -95% | -$669K | ﹤0.01% | 6992 |
|
|
2022
Q2 | $667K | Buy |
11,986
+11,754
| +5,066% | +$667K | ﹤0.01% | 3094 |
|
|
2022
Q1 | $16K | Buy |
+232
| New | +$16.8K | ﹤0.01% | 8465 |
|
|
2020
Q1 | – | Sell |
-3,411
| Closed | -$193K | – | 7950 |
|
|
2019
Q4 | $221K | Buy |
3,411
+2,154
| +171% | +$144K | ﹤0.01% | 3644 |
|
|
2019
Q3 | $78K | Buy |
+1,257
| New | +$78.9K | ﹤0.01% | 4582 |
|
|
2018
Q4 | – | Sell |
-3,908
| Closed | -$417K | – | 7444 |
|
|
2018
Q3 | $669K | Buy |
3,908
+734
| +23% | +$111K | ﹤0.01% | 2313 |
|
|
2018
Q2 | $410K | Buy |
+3,174
| New | +$354K | ﹤0.01% | 2659 |
|
|
2018
Q1 | – | Sell |
-3,217
| Closed | -$318K | – | 6527 |
|
|
2017
Q4 | $274K | Buy |
3,217
+668
| +26% | +$57.9K | 0.01% | 1066 |
|
|
2017
Q3 | $216K | Buy |
+2,549
| New | +$202K | 0.01% | 1139 |
|
|
2017
Q2 | – | Sell |
-9,293
| Closed | -$650K | – | 6469 |
|
|
2017
Q1 | $613K | Buy |
9,293
+9,243
| +18,486% | +$608K | 0.03% | 576 |
|
|
2016
Q4 | $3K | Sell |
50
-6,328
| -99% | -$399K | ﹤0.01% | 4752 |
|
|
2016
Q3 | $406K | Buy |
6,378
+862
| +16% | +$63.3K | 0.03% | 609 |
|
|
2016
Q2 | $410K | Buy |
5,516
+5,118
| +1,286% | +$380K | 0.03% | 612 |
|
|
2016
Q1 | $26K | Sell |
398
-1,599
| -80% | -$97.2K | ﹤0.01% | 2553 |
|
|
2015
Q4 | $135K | Sell |
1,997
-347
| -15% | -$21.4K | 0.01% | 1136 |
|
|
2015
Q3 | $125K | Buy |
+2,344
| New | +$142K | 0.01% | 1241 |
|
Other funds holding LGND
JT
CAM
Simplex Trading's LGND Position: Q2 2026 in Review
Simplex Trading opened a new position in Ligand Pharmaceuticals (LGND) in Q2 2026: 1,446 shares worth $457K. The stake represents ﹤0.01% of the portfolio and ranks #3718 among its holdings. This is a return to the name: Simplex Trading previously reported a position in LGND as recently as Q4 2025.
Simplex Trading first reported a position in LGND in Q3 2015 and has held it in 23 quarters since. The position peaked at $669K in Q3 2018. 414 funds tracked by Wall St. Rank hold LGND as of Q2 2026.
- Simplex Trading held 1,446 shares of Ligand Pharmaceuticals worth $457K as of Q2 2026.
- Ligand Pharmaceuticals was a new Simplex Trading position in Q2 2026.
- Ligand Pharmaceuticals made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #3718 holding.
- Simplex Trading first reported a position in Ligand Pharmaceuticals in Q3 2015 and has held it in 23 quarters since.
- Simplex Trading's Ligand Pharmaceuticals position peaked at $669K in Q3 2018.
- 414 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.
Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.